Optic Neuropathy and Myelopathy in a Teenager With Biotinidase Deficiency

J Neuroophthalmol. 2024 Sep 1;44(3):437-440. doi: 10.1097/WNO.0000000000002088. Epub 2024 Feb 7.

Abstract

A 19-year-old man presented with 3 years of gradually progressive, painless vision loss in both eyes. The ophthalmic examination showed bilateral diminished visual acuity, dyschromatopsia, and temporal optic nerve pallor. The neurological examination was consistent with a mild myelopathy with decreased pin-prick sensation starting at T6-T7 and descending through the lower extremities. Hyperreflexia was also present in the lower more than upper extremities. Infectious, inflammatory, and nutritional serum workup and cerebrospinal fluid analysis were both unrevealing. MRI of the brain and spinal cord showed abnormal T2 hyperintensity of the fornix, corpus callosum, optic nerves, and lateral columns of the cervical and thoracic spine, with diffusion restriction in the inferior-posterior corpus callosum and fornix. Biotinidase serum enzyme activity was tested and showed a decreased level of activity. Biotinidase gene testing showed a homozygous pathogenic variant, c.424C>A (p.P142T), confirming the diagnosis of biotinidase deficiency and prompting oral biotin supplementation. Three months after starting treatment, the patient's visual acuity, color vision, visual fields, and MRI spine abnormalities all improved significantly. Biotinidase deficiency is an important diagnostic consideration in patients with unexplained optic neuropathy and/or myelopathy.

Publication types

  • Case Reports

MeSH terms

  • Biotinidase Deficiency* / complications
  • Biotinidase Deficiency* / diagnosis
  • Humans
  • Magnetic Resonance Imaging*
  • Male
  • Optic Nerve Diseases* / diagnosis
  • Optic Nerve Diseases* / etiology
  • Spinal Cord / diagnostic imaging
  • Spinal Cord Diseases* / diagnosis
  • Spinal Cord Diseases* / etiology
  • Visual Acuity / physiology
  • Young Adult